Abiopharma

New Form SCHEDULE 13G/A - Praxis Precision Medicines, Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072732 Size: 10 KB

New Form SCHEDULE 13G/A - Edgewise Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072730 Size: 10 KB

New Form SCHEDULE 13G/A - Ensysce Biosciences, Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072727 Size: 10 KB

New Form SCHEDULE 13G/A - INSMED Inc Filed: 2025-05-15 AccNo: 0000902664-25-002416 Size: 11 KB

New Form SCHEDULE 13G - BIODESIX INC Filed: 2025-05-15 AccNo: 0000950170-25-072726 Size: 30 KB

New Form 144 - EXELIXIS, INC. Filed: 2025-05-15 AccNo: 0001950047-25-003083 Size: 5 KB

New Form NT 10-Q - EXICURE, INC. Filed: 2025-05-15 AccNo: 0001698530-25-000040 Size: 34 KB

New Form 4 - INSMED Inc Filed: 2025-05-15 AccNo: 0001628280-25-025980 Size: 6 KB

New Form DEFA14A - Fortrea Holdings Inc. Filed: 2025-05-15 AccNo: 0001965040-25-000032 Size: 53 KB

New Form 8-K - Travere Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001438533-25-000032 Size: 168 KB Item 8.01: Other Events

Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with New Concentration

Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results

New Form SCHEDULE 13G - BiomX Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002387 Size: 9 KB

New Form SCHEDULE 13G/A - 4D Molecular Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0000921895-25-001547 Size: 25 KB

New Form SCHEDULE 13G/A - Sagimet Biosciences Inc. Filed: 2025-05-15 AccNo: 0000902664-25-002414 Size: 12 KB